Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:53 PM
Ignite Modification Date:
2025-12-24 @ 1:53 PM
NCT ID:
NCT02765295
Eligibility Criteria:
Inclusion Criteria:
* Out-patients of either gender, ex- or never-smokers, aged between 18 and 75 years
* Clinically stable bronchiectasis, defined as respiratory symptoms and lung function parameters not exceeding normal daily variations and no acute upper respiratory tract infections for 4 consecutive weeks
* Patients with a history of 2 or more bronchiectasis exacerbations (BEs) within the previous 2 years
Exclusion Criteria:
* Other unstable concomitant systemic illnesses (i.e. coronary heart disease, recent cerebral stroke, severe uncontrolled hypertension, active gastric or duodenal ulcer, uncontrolled diabetes, malignancy, hepatic or renal dysfunction)
* Concomitant asthma, allergic bronchopulmonary aspergillosis, or active tuberculosis
* Concomitant chronic obstructive pulmonary disease as the predominant diagnosis
* Treatment with inhaled, oral or systemic antibiotics within 4 weeks
* Type 2 respiratory failure needing oxygen therapy or non-invasive mechanical ventilation
* Females during lactation or pregnancy
* Poor understanding or failure to properly operate the instrument
* Participation in other clinical trials within 3 months.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02765295
Study Brief:
Protocol Section:
NCT02765295